Literature DB >> 6142096

A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.

P L Wood, P Etienne, S Lal, N P Nair, M H Finlayson, S Gauthier, J Palo, M Haltia, A Paetau, E D Bird.   

Abstract

Assessment of neurochemical markers in the frontal cortex indicates that choline acetyltransferase is significantly decreased in Alzheimer's and Gerstmann-Straussler dementias but not in Pick's dementia. It therefore appears that the cholinergic innervation of the cortex from the basal forebrain is intact in Pick's disease. Cortical somatostatin was decreased only in Alzheimer's disease (AD), indicating that loss of somatostatin is not a constant feature in different forms of dementia. Muscarinic binding sites were unaltered in Pick's disease and Gerstmann-Straussler syndrome but were decreased in a subpopulation of AD patients. These data suggest that in some cases of AD a significant loss of cholinoceptive neurones in the cortex is evident.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6142096     DOI: 10.1016/0022-510x(83)90200-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Parvalbumin-immunoreactive neurons in the cortex in Pick's disease.

Authors:  H Arai; I Noguchi; Y Makino; K Kosaka; C W Heizmann; R Iizuka
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

Review 2.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

3.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

Review 4.  A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.

Authors:  Edward D Huey; Karen T Putnam; Jordan Grafman
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

5.  Increased CSF HVA response to arecoline challenge in Alzheimer's disease.

Authors:  N Pomara; M Stanley; P A LeWitt; M Galloway; R Singh; D Deptula
Journal:  J Neural Transm Gen Sect       Date:  1992

6.  Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.

Authors:  Elizabeth Scarr; Catriona McLean; Brian Dean
Journal:  J Neural Transm (Vienna)       Date:  2016-09-29       Impact factor: 3.575

7.  Neocortical morphometry and cholinergic neurochemistry in Pick's disease.

Authors:  L A Hansen; R Deteresa; H Tobias; M Alford; R D Terry
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

Review 8.  Neurotransmitter deficits from frontotemporal lobar degeneration.

Authors:  Alexander G Murley; James B Rowe
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

9.  Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.

Authors:  Uma V Mahajan; Vijay R Varma; Michael E Griswold; Chad T Blackshear; Yang An; Anup M Oommen; Sudhir Varma; Juan C Troncoso; Olga Pletnikova; Richard O'Brien; Timothy J Hohman; Cristina Legido-Quigley; Madhav Thambisetty
Journal:  PLoS Med       Date:  2020-01-24       Impact factor: 11.069

Review 10.  Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.

Authors:  Changiz Geula; Sara R Dunlop; Ivan Ayala; Allegra S Kawles; Margaret E Flanagan; Tamar Gefen; Marek-Marsel Mesulam
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.